ReviewBiomedicines2024

Revisiting Treatment of Metastatic Urothelial Cancer: Where Do Cisplatin and Platinum Ineligibility Criteria Stand?

Mohammad Jad Moussa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.